Boston University
room 765 Commonwealth Ave
arrow_back See all Activities

BioVersys - Anti-Virulence Adjunctive Therapy Against Resistant Staphylococus aureus (AVATAR-SA)

IATI Identifier:

Published on IATI
  • date_range Nov 01, 2019 - Apr 30, 2021
  • autorenew Implementation (Status)

Anti-Virulence Adjunctive Therapy Against Resistant Staphylococus aureus (AVATAR-SA)

more_horiz
Sectors:

  • Infectious disease control

Participating Organisations

BioVersys Private Sector Implementing

Transaction

Transaction Value Provider
Receiver 		Type Date
Not Available Provider N/A Receiver N/A
date_range

Budget

1,969,092 USD
  • 1,969,092 USD (Valued at Feb 04, 2020)
    date_range Nov 01, 2019 - Mar 31, 2020
access_time Updated on Apr 26, 2022 02:29:16